LISTSERV - IRIS Archives - LISTSERV.ICORS.ORG

IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG

	LISTSERV Archives
	IRIS Home

	Log In
	Register

	Subscribe or Unsubscribe

	Search Archives

Options:	Use Forum View Use Monospaced Font Show Text Part by Default Show All Mail Headers
Message:	[<< First] [< Prev] [Next >] [Last >>]
Topic:	[<< First] [< Prev] [Next >] [Last >>]
Author:	[<< First] [< Prev] [Next >] [Last >>]

Subject:	Fanapt for Sz
From:	Sylvia Caras <[log in to unmask]>
Reply To:	[log in to unmask]
Date:	Mon, 25 Jan 2010 07:57:15 -0800
Content-Type:	text/plain
Parts/Attachments:	text/plain (13 lines)

Novartis Launches Schizophrenia Treatment Fanapt in the US, Offering 
Patients an Attractive Alternative to Existing Medications

 From Hugin (English) - Jan 11, 2010
Basel, January 11, 2010 - Novartis announced that Fanapt 
(iloperidone) tablets are now available for use across the US for the 
acute treatment of schizophrenia in adults. Fanapt is a twice- daily, 
oral antipsychotic, approved by the FDA in May 2009.



Powered by LSoft's LISTSERV(R) list management software

ATOM RSS1 RSS2

LISTSERV.ICORS.ORG